Azathioprine Completed Phase 2 / 3 Trials for Neuromyelitis Optica Spectrum Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs